PFx Biotech Secures $2.5M Seed Round to Revolutionize Nutritious and Sustainable Protein Production

PFx Biotech is thrilled to announce that we have successfully raised €2,500,000 in our latest funding round, a significant milestone that propels our mission of creating healthier lives and a better planet. As a cutting-edge biotechnology company founded in 2022 and based in UPTEC, Porto, we harness the power of biology to revolutionize early life nutrition by producing highly bioactive, alternative human milk proteins through precision fermentation. Human milk proteins, known as the golden standard in nutrition during early life, form the backbone of our innovation as we develop a new category of ingredients that support and boost the immune system. Our breakthrough proteins are non-allergenic, GMO-free, dairy-free, and animal-free, making them not only ideal for next-generation infant formula but also a superior nutritional option for elderly populations and athletes who face specific dietary challenges. This funding will enable us to accelerate research and development, optimize our production processes, and scale our operations to meet growing global demand. With the expertise of our passionate team, which accumulates a wealth of experience in dairy proteins, fermentation, molecular biology, and scale-up technology, we are committed to disrupting conventional protein production systems while remaining environmentally friendly and socially responsible. This infusion of capital underscores investor confidence in our vision, and it energizes our ongoing efforts to create innovative, inclusive, and sustainable nutritional solutions that have the potential to positively impact millions of lives worldwide.